Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Charles River Laboratories
AddedMar 19, 2024
UpdatedJul 9, 2026
Charles River Laboratories

Charles River Laboratories

Public

Global biomedical research support for drug development.

HQ
Wilmington, MA, US
Founded
1947
Overview
Compare
Fundraising
Employees

Founded in Wilmington, Massachusetts, Charles River Laboratories International, Inc. is a global non-clinical contract research organization dedicated to advancing drug discovery and development. The company offers a comprehensive range of services including drug discovery, non-clinical development, and safety testing. Operating through three main segments—Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions—Charles River provides essential support for the biomedical research community worldwide.

Notable figures associated with Charles River Laboratories include key scientists and industry experts who drive innovation within the company. The organization has attracted significant investment from leading healthcare and biotech investors. Key achievements include pioneering advancements in drug safety testing and expanding their global footprint to serve clients in the United States, Europe, Canada, and the Asia Pacific. Overall, Charles River Laboratories has had a profound impact on the biomedical research field, facilitating critical developments in drug discovery and safety assessment.

Charles River Laboratories - Similar Companies

Thermo Fisher th logo

Thermo Fisher th

thermofisher.com

Quintiles logo

Quintiles

quintiles.com

Novartis Institutes For Biomedical Research logo

Novartis Institutes For Biomedical Research

novartis.com

Cayman Chemical Company logo

Cayman Chemical Company

Bio-Rad logo

Bio-Rad

bio-rad.com

Confluence Discovery Technologies logo

Confluence Discovery Technologies

WuXi Biologics logo

WuXi Biologics

wuxibiologics.com

Catalent logo

Catalent

catalent.com

ABC Laboratories logo

ABC Laboratories

abclabs.com

Novartis logo

Novartis

novartis.com

Harvard Bioscience logo

Harvard Bioscience

Revvity logo

Revvity

LabConnect logo

LabConnect

labconnect.com

Societal Cdmo logo

Societal Cdmo

societalcdmo.com

Syneos Health logo

Syneos Health

syneoshealth.com

Charles River Laboratories - Quick Facts

Who are Charles River Laboratories' competitors?

Companies similar to Charles River Laboratories include Thermo Fisher th, Quintiles, Novartis Institutes For Biomedical Research and Cayman Chemical Company.

When was Charles River Laboratories founded?

Charles River Laboratories was founded in 1947.

Where is Charles River Laboratories' headquarters located?

Charles River Laboratories' headquarters is located in Wilmington, MA, US.

When was Charles River Laboratories' last funding round?

Charles River Laboratories' most recent funding round was for $1B (USD) in March 2021.

How much has Charles River Laboratories raised to-date?

As of Mar 23, 2021, Charles River Laboratories has raised a total of $1.5B (USD).

How many employees does Charles River Laboratories have?

Charles River Laboratories has 20,000 employees as of Feb 6, 2024.

Charles River Laboratories - Classification

Industry
  • Professional Service Companies
Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Transactional
Customer
  • Enterprise
  • Small Business
Main Product
  • Drug Development
  • Safety Testing
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 7210Research and experimental development on natural sciences and engineering
Show 28 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325414Biological Product (except Diagnostic) Manufacturing
  • 541713Research and Development in Nanotechnology
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 610000Educational Services
  • 611300Colleges, Universities, and Professional Schools
  • 611310Colleges, Universities, and Professional Schools
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 611000Educational Services
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2836Biological Products, Except Diagnostic Substances
  • 8220Colleges, Universities, Professional Schools, And Junior Colleges
  • 8221Colleges, Universities, And Professional Schools
  • 2800Chemicals And Allied Products
  • 4000Railroad Transportation
  • 6000Depository Institutions
  • 8000Health Services
  • 8200Educational Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8290Schools And Educational Services, Not Elsewhere Classified
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products